tm logo
CHRYSALIS BIOTHERAPEUTICS
Live/Pending
STATEMENT OF USE - TO EXAMINER

to examiner

on 03 Jan 2025

Last Applicant/ Owned by

2200 Market Street, Suite 604

Galveston

TX

77550

Serial Number

90052179 filed on 14th Jul 2020

Registration Number

N/A

Correspondent Address

Shannon T. Vale

Shannon T. Vale Pirkey Barber PLLC

Austin, TX 78702

UNITED STATES

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

CHRYSALIS BIOTHERAPEUTICS

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diabetic foot ulcers; Pharmaceutical preparations for accelerating healing of human tissue; Therapeutic gels intended for topical use on skin and mucous membranes, intended to accelerate the healing of skin surface wounds and Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diabetic foot ulcers; Pharmaceutical preparations for accelerating healing of human tissue; Therapeutic gels intended for topical use on skin and mucous membranes, intended to accelerate the healing of skin surface wounds and diabetic foot ulcers; Pharmaceuticals for the treatment of acute radiation syndrome; Pharmaceuticals for the treatment of COVID-19; Pharmaceutical products for the prevention and treatment of Degenerative Brain Diseases and Traumatic Brain Injury (TBI)


First Use Date in General

31st May 2019

First Use Date in Commerce

31st May 2019

Mark Details


Serial Number

No 90052179

Mark Type

No Service/Collective Mark

Attorney Docket Number

No CBIO004US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
03rd Jan 2025STATEMENT OF USE PROCESSING COMPLETE
02th Jan 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
13th May 2024TEAS STATEMENT OF USE RECEIVED
13th May 2024USE AMENDMENT FILED
18th Nov 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
17th Nov 2023SOU EXTENSION 5 GRANTED
17th Nov 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
10th Nov 2023SOU EXTENSION 5 FILED
10th Nov 2023SOU TEAS EXTENSION RECEIVED
10th May 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED